---
name: Michael Sellers Cuoco
position: "PhD Student, Bioinformatics and Systems Biology"
address: "University of California, San Diego"
phone: "(978) 505-0993" 
email: mcuoco@ucsd.edu
twitter: cuoco_michael
github: mikecuoco
orcid: "0000-0003-2163-5120"
# aboutme: "Molecular biologist and bioinformatician focused on gene regulation in cancer evolution and drug resistance. Interested in decoding and modeling the human cell."
date: "Updated August 28 2020"
headcolor: "00008B"
output: 
  vitae::hyndman: 
    keep_md: true
---



# Education 
\detailedsection{\detaileditem{Postbaccalaureate coursework}{May 2016--May 2018}{Cambridge, Massachusetts}{Harvard Extension School}{\empty}\detaileditem{BS in Cellular and Molecular Biology}{Sep 2012--May 2016}{Hartford, Connecticut}{Trinity College}{\item{Minor: Models and Data}\item{Major GPA: 3.62}}}
# Honors and Awards

\detailedsection{\detaileditem{Spot Award}{2017}{Cambridge, Massachusetts}{Broad Institute}{\item{Awarded to nominees to acknowledge and demonstrate appreciation and recognition for their exceptional contributions.}}\detaileditem{TriBeta National Biology Honors Society}{2014}{Hartford, Connecticut}{Trinity College}{\item{Dedicated to improving the understanding and appreciation of biological study and extending boundaries of human knowledge through scientific research. Members must meet the national membership criteria.}}\detaileditem{NESCAC Winter All-Academic Team}{2014}{Hartford, Connecticut}{Trinity College}{\item{Student-athletes must have reached sophomore academic standing, and be in good standing in their sport with a cumulative grade point average of at least 3.50.}}}

# Experience

\detailedsection{\detaileditem{Research Associate}{Aug 2016--Aug 2020}{Cambridge, Massachusetts}{Aviv Regev Lab, Broad Institute, MIT \& Harvard University}{\item{Collaborated with teams of physicians and scientists to characterize signatures of cancer drug resistance by single-cell and bulk transcriptome and chromatin profiling of patient, mouse, and cell line samples. Conducted functional investigation by pooled genetic perturbation experiments.}}\detaileditem{Undergraduate Student}{May 2014--Aug 2015}{Boston, Massachusetts}{Matthew Meyerson Lab, Dana-Farber Cancer Institute, Harvard Medical School}{\item{Undergraduate thesis: Engineered an in vitro model of chromosome arm 8p loss by CRISPR/Cas9 editing and artificial telomere recombination to investigate the functional consequences of the common cancerous alteration.}}\detaileditem{Undergraduate Student}{Sep 2012--Dec 2013}{Hartford, Connecticut}{SEA-PHAGES, Genomics Research Program, Trinity College}{\empty}\detaileditem{High school Student}{Jun 2011--Jul 2011}{Boston, Massachusetts}{Alan D'Andrea Lab, Dana-Farber Cancer Institute, Harvard Medical School}{\empty}}

\pagebreak

# Professional Training

\detailedsection{\detaileditem{Harvard Biotech Incubator}{2018}{Boston, Massachusetts}{Harvard Biotech Club}{\item{Worked directly with company founding members and key opinion leaders, performing due diligence and market research to identify clinical indications for therapeutic technology.}}\detaileditem{Patent Law Short Course}{2018}{Boston, Massachusetts}{Harvard Biotech Club}{\item{Reviewed basic concepts of patent law through weekly case readings and workshops at a local firm.}}\detaileditem{Heatlhcare Innovation \& Commercialization Short Course}{2017}{Boston, Massachusetts}{Harvard Biotech Club}{\item{Weekly modules addressed various aspects of the commercialization process of biomedical technology including intellectual property, market sizing, clinical paths, and FDA regulation.}}}

# Teaching

\detailedsection{\detaileditem{CodeRATS}{2018}{Cambridge, Massachusetts}{Broad Institute}{\item{Managed the leadership team for a series of institute-wide introduction to programming workshops.}}\detaileditem{Teaching Assistant}{2015-2016}{Hartford, Connecticut}{Trinity College}{\item{Hosted study sessions on topics in genetics}}\detaileditem{Tutor}{2015-2016}{Hartford, Connecticut}{Trinity College}{\item{Tutored biology and genetics students one-on-one by request}}}

# Authored Publications



**Published**

\detailedsection{\detaileditem{Acquired FGFR and FGF alterations confer resistance to estrogen receptor (ER) targeted therapy in ER+ metastatic breast cancer.}{Jul 30, 2020}{\newline P Mao, O Cohen, KJ Kowalski, J Kusiel, JE Buendia-Buendia, \underline{MS Cuoco}, P Exman, SA Wander, AG Waks, U Nayar, JH Chung, SS Freeman, O Rozenblatt-Rosen, VA Miller, F Piccioni, DE Root, A Regev, EP Winer, NU Lin, N Wagle}{{\textit{Clinical cancer research : an official journal of the American Association for Cancer Research}}  {\color{blue} \underline{\href{www.doi.org/10.1158/1078-0432.CCR-19-3958}{doi.org/10.1158/1078-0432.CCR-19-3958}}}}{\empty}\detaileditem{A single-cell landscape of high-grade serous ovarian cancer.}{Jun 24, 2020}{\newline B Izar, I Tirosh, EH Stover, I Wakiro, \underline{MS Cuoco}, I Alter, C Rodman, R Leeson, MJ Su, P Shah, M Iwanicki, SR Walker, A Kanodia, JC Melms, S Mei, JR Lin, CBM Porter, M Slyper, J Waldman, L Jerby-Arnon, O Ashenberg, TJ Brinker, C Mills, M Rogava, S Vigneau, PK Sorger, LA Garraway, PA Konstantinopoulos, JF Liu, U Matulonis, BE Johnson, O Rozenblatt-Rosen, A Rotem, A Regev}{{\textit{Nature medicine}}  {\color{blue} \underline{\href{www.doi.org/10.1038/s41591-020-0926-0}{doi.org/10.1038/s41591-020-0926-0}}}}{\empty}\detaileditem{IL-33 Signaling Alters Regulatory T Cell Diversity in Support of Tumor Development.}{Dec 5, 2019}{\newline A Li, RH Herbst, D Canner, JM Schenkel, OC Smith, JY Kim, M Hillman, A Bhutkar, \underline{MS Cuoco}, CG Rappazzo, P Rogers, C Dang, L Jerby-Arnon, O Rozenblatt-Rosen, L Cong, M Birnbaum, A Regev, T Jacks}{{\textit{Cell reports}}  {\color{blue} \underline{\href{www.doi.org/10.1016/j.celrep.2019.10.120}{doi.org/10.1016/j.celrep.2019.10.120}}}}{\empty}\detaileditem{Acquired HER2 mutations in ER+ metastatic breast cancer confer resistance to estrogen receptor-directed therapies.}{Dec 12, 2018}{\newline U Nayar, O Cohen, C Kapstad, \underline{MS Cuoco}, AG Waks, SA Wander, C Painter, S Freeman, NS Persky, L Marini, K Helvie, N Oliver, O Rozenblatt-Rosen, CX Ma, A Regev, EP Winer, NU Lin, N Wagle}{{\textit{Nature genetics}}  {\color{blue} \underline{\href{www.doi.org/10.1038/s41588-018-0287-5}{doi.org/10.1038/s41588-018-0287-5}}}}{\empty}\detaileditem{A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade.}{Nov 6, 2018}{\newline L Jerby-Arnon, P Shah, \underline{MS Cuoco}, C Rodman, MJ Su, JC Melms, R Leeson, A Kanodia, S Mei, JR Lin, S Wang, B Rabasha, D Liu, G Zhang, C Margolais, O Ashenberg, PA Ott, EI Buchbinder, R Haq, FS Hodi, GM Boland, RJ Sullivan, DT Frederick, B Miao, T Moll, KT Flaherty, M Herlyn, RW Jenkins, R Thummalapalli, MS Kowalczyk, I Cañadas, B Schilling, ANR Cartwright, AM Luoma, S Malu, P Hwu, C Bernatchez, MA Forget, DA Barbie, AK Shalek, I Tirosh, PK Sorger, K Wucherpfennig, EM Van Allen, D Schadendorf, BE Johnson, A Rotem, O Rozenblatt-Rosen, LA Garraway, CH Yoon, B Izar, A Regev}{{\textit{Cell}}  {\color{blue} \underline{\href{www.doi.org/10.1016/j.cell.2018.09.006}{doi.org/10.1016/j.cell.2018.09.006}}}}{\empty}\detaileditem{The neuropeptide NMU amplifies ILC2-driven allergic lung inflammation.}{Sep 14, 2017}{\newline A Wallrapp, SJ Riesenfeld, PR Burkett, RE Abdulnour, J Nyman, D Dionne, M Hofree, \underline{MS Cuoco}, C Rodman, D Farouq, BJ Haas, TL Tickle, JJ Trombetta, P Baral, CSN Klose, T Mahlakõiv, D Artis, O Rozenblatt-Rosen, IM Chiu, BD Levy, MS Kowalczyk, A Regev, VK Kuchroo}{{\textit{Nature}}  {\color{blue} \underline{\href{www.doi.org/10.1038/nature24029}{doi.org/10.1038/nature24029}}}}{\empty}\detaileditem{Whole genome comparison of a large collection of mycobacteriophages reveals a continuum of phage genetic diversity.}{Apr 29, 2015}{\newline WH Pope, CA Bowman, DA Russell, D Jacobs-Sera, DJ Asai, SG Cresawn, WR Jacobs, RW Hendrix, JG Lawrence, GF Hatfull {\\\underline{MS Cuoco} listed at co-investigator}}{{\textit{eLife}}  {\color{blue} \underline{\href{www.doi.org/10.7554/eLife.06416}{doi.org/10.7554/eLife.06416}}}}{\empty}}

**Preprint**

\detailedsection{\detaileditem{Single-nucleus and spatial transcriptomics of archival pancreatic cancer reveals multi-compartment reprogramming after neoadjuvant treatment}{Aug 25, 2020}{\newline WL Hwang, KA Jagadeesh, JA Guo, HI Hoffman, P Yadollahpour, R Mohan, E Drokhlyansky, N Van Wittenberghe, O Ashenberg, S Farhi, D Schapiro, JW Reeves, DR Zollinger, G Eng, JM Schenkel, WA Freed-Pastor, C Rodrigues, J Gould, C Lambden, C Porter, A Tsankov, D Dionne, D Abbondanza, J Waldman, \underline{MS Cuoco}, L Nguyen, T Delorey, D Phillips, D Ciprani, M Kern, A Mehta, K Fuhrman, R Fropf, JM Beechem, JS Loeffler, DP Ryan, CD Weekes, DT Ting, CR Ferrone, JY Wo, TS Hong, AJ Aguirre, NA Rozen}{{\textit{bioRxiv}}  {\color{blue} \underline{\href{www.doi.org/10.1101/2020.08.25.267336}{doi.org/10.1101/2020.08.25.267336}}}}{\empty}\detaileditem{RAAS blockade, kidney disease, and expression of ACE2, the entry receptor for SARS-CoV-2, in kidney epithelial and endothelial cells}{Jul 1, 2020}{\newline A Subramanian, K Vernon, M Slyper, J Waldman, MD Luecken, K Gosik, D Dubinsky, \underline{MS Cuoco}, K Keller, J Purnell, L Nguyen, D Dionne, O Rozenblatt-Rosen, A Weins, Human Cell Atlas Lung Biological Network, A Regev, A Greka}{{\textit{bioRxiv}}  {\color{blue} \underline{\href{www.doi.org/10.1101/2020.06.23.167098}{doi.org/10.1101/2020.06.23.167098}}}}{\empty}\detaileditem{Cycling cancer persister cells arise from lineages with distinct transcriptional and metabolic programs}{Jun 5, 2020}{\newline Y Oren, M Tsabar, HF Cabanos, \underline{MS Cuoco}, E Zaganjor, PI Thakore, M Tabaka, CP Fulco, SA Hurvitz, DJ Slamon, G Lahav, A Hata, JS Brugge, A Regev}{{\textit{bioRxiv}}  {\color{blue} \underline{\href{www.doi.org/10.1101/2020.06.05.136358}{doi.org/10.1101/2020.06.05.136358}}}}{\empty}\detaileditem{Integrated analyses of single-cell atlases reveal age, gender, and smoking status associations with cell type-specific expression of mediators of SARS-CoV-2 viral entry and highlights inflammatory programs in putative target cells}{Apr 21, 2020}{\newline C Muus, MD Luecken, G Eraslan, A Waghray, G Heimberg, L Sikkema, Y Kobayashi, ED Vaishnav, A Subramanian, C Smillie, K Jagadeesh, ET Duong, E Fiskin, E Torlai Triglia, C Becavin, M Ansari, P Cai, B Lin, J Buchanan, S Chen, J Shu, AL Haber, H Chung, DT Montoro, T Adams, H Aliee, SJ Allon, Z Andrusivova, I Angelidis, O Ashenberg, K Bassler, C Becavin, I Benhar, J Bergenstrahle, L Bergenstrahle, L Bolt, E Braun, LT Bui, M Chaffin, E Chichelnitskiy, J Chiou, TM Conlon, \underline{MS Cuoco}, M Deprez, NA Fisc}{{\textit{bioRxiv}}  {\color{blue} \underline{\href{www.doi.org/10.1101/2020.04.19.049254}{doi.org/10.1101/2020.04.19.049254}}}}{\empty}\detaileditem{Transcriptional mediators of treatment resistance in lethal prostate cancer}{Mar 20, 2020}{\newline MX He, \underline{MS Cuoco}, J Crowdis, A Bosma-Moody, Z Zhang, K Bi, A Kanodia, M-J Su, C Rodman, L DelloStritto, P Shah, KP Burke, B Izar, Z Bakouny, AK Tewari, D Liu, SY Camp, NI Vokes, J Park, S Vigneau, L Fong, O Rozenblatt-Rosen, A Regev, A Rotem, M-E Taplin, EM Van Allen}{{\textit{bioRxiv}}  {\color{blue} \underline{\href{www.doi.org/10.1101/2020.03.19.998450}{doi.org/10.1101/2020.03.19.998450}}}}{\empty}\detaileditem{Pan-cancer single cell RNA-seq uncovers recurring programs of cellular heterogeneity}{Oct 21, 2019}{\newline GS Kinker, AC Greenwald, R Tal, Z Orlova, \underline{MS Cuoco}, JM McFarland, A Warren, C Rodman, JA Roth, SA Bender, B Kumar, JW Rocco, PA Fernandes, CC Mader, H Keren-Shaul, A Plotnikov, H Barr, A Tsherniak, O Rozenblatt-Rosen, V Krizhanovsky, SV Puram, A Regev, I Tirosh}{{\textit{bioRxiv}}  {\color{blue} \underline{\href{www.doi.org/10.1101/807552}{doi.org/10.1101/807552}}}}{\empty}\detaileditem{Acquired FGFR and FGF alterations confer resistance to estrogen receptor (ER) targeted therapy in ER+ metastatic breast cancer}{Oct 7, 2019}{\newline P Mao, O Cohen, KJ Kowalski, JG Kusiel, JE Buendia-Buendia, \underline{MS Cuoco}, P Exman, SA Wander, AG Waks, U Nayar, J Chung, S Freeman, O Rozenblatt-Rosen, VA Miller, F Federica Piccioni, DE Root, A Regev, EP Winer, NU Lin, N Wagle}{{\textit{bioRxiv}}  {\color{blue} \underline{\href{www.doi.org/10.1101/605436}{doi.org/10.1101/605436}}}}{\empty}\detaileditem{The enteric nervous system of the human and mouse colon at a single-cell resolution}{Sep 4, 2019}{\newline E Drokhlyansky, CS Smillie, N Van Wittenberghe, M Ericsson, GK Griffin, D Dionne, \underline{MS Cuoco}, MN Goder-Reiser, T Sharova, AJ Aguirre, GM Boland, D Graham, O Rozenblatt-Rosen, RJ Xavier, A Regev}{{\textit{bioRxiv}}  {\color{blue} \underline{\href{www.doi.org/10.1101/746743}{doi.org/10.1101/746743}}}}{\empty}\detaileditem{Opposing immune and genetic forces shape oncogenic programs in synovial sarcoma}{Aug 4, 2019}{\newline L Jerby, C Neftel, ME Shore, MJ McBride, B Haas, B Izar, HR Weissman, A Volorio, G Boulay, L Cironi, AR Richman, LC Broye, JM Gurski, CC Luo, R Mylvaganam, L Nguyen, S Mei, Jc Melms, C Georgescu, O Cohen, JE Buendia-Buendia, \underline{MS Cuoco}, D Labes, DR Zollinger, JM Beechem, P Nielsen, I Chebib, G Cote, E Choy, I Letovanec, S Cherix, N Wagle, PK Sorger, AB Haynes, JT Mullen, I Stamenkovic, MN Rivera, C Kadoch, O Rozenblatt-Rosen, ML Suva, N Riggi, A Regev}{{\textit{bioRxiv}}  {\color{blue} \underline{\href{www.doi.org/10.1101/724302}{doi.org/10.1101/724302}}}}{\empty}\detaileditem{Longitudinal single cell profiling of regulatory T cells identifies IL-33 as a driver of tumor immunosuppression}{Jan 6, 2019}{\newline A Li, RH Herbst, D Canner, JM Schenkel, OC Smith, JY Kim, M Hillman, A Bhutkar, \underline{MS Cuoco}, CG Rappazzo, P Rogers, CQ Dang, O Rozenblatt-Rosen, L Cong, M Birnbaum, A Regev, T Jacks}{{\textit{bioRxiv}}  {\color{blue} \underline{\href{www.doi.org/10.1101/512905}{doi.org/10.1101/512905}}}}{\empty}}

*Publications and preprints are updated programmatically.*

# Presentations



**Talks**

\detailedsection{\detaileditem{The cellular origins of drug resistance in cancer}{Apr 2020}{}{Regev Lab Staff Meeting; Cambridge, Massachusetts}{\empty}\detaileditem{CRISPR screening for regulators of cancer immune checkpoint inhibitor resistance}{Oct 2018}{}{Regev Lab Science Days Retreat; Cambridge, Massachusetts}{\empty}\detaileditem{Understanding the mechanisms of drug resistance in melanoma}{May 2017}{}{Regev Lab Staff Meeting; Cambridge, Massachusetts}{\empty}\detaileditem{In vitro modeling and analysis of chromosome 8p arm-level deletion using CRISPR-Cas9.}{May 2016}{}{Trinity College Biology Department; Hartford, Connecticut}{\empty}\detaileditem{In vitro modeling and analysis of chromosome 8p arm-level deletion using CRISPR-Cas9.}{Aug 2015}{}{Meyerson Lab Group Meeting; Boston, Massachusetts}{\empty}\detaileditem{Genome engineering to generate models of chromosome arm-level aneuploidies.}{Aug 2014}{}{Meyerson Lab Group Meeting; Boston, Massachusetts}{\empty}\detaileditem{The role of the FANCD2 gene in Fanconi Anemia and DNA repair.}{Nov 2012}{}{Concord-Carlisle High School STEM series; Concord, Massachusetts}{\empty}}

**Posters**

\detailedsection{\detaileditem{Metabolic switching underlies the ability of cancer persister cells to cycle under drug treatment.}{Dec 2019}{}{Annual Broad Institute Retreat; Boston, Massachusetts}{\empty}\detaileditem{Targeting the root of non-genetic cancer relapse using an expressed barcode library.}{Feb 2019}{}{Annual Klarman Cell Observatory Retreat; Cambridge, Massachusetts}{\empty}\detaileditem{Discovering the master regulators of immune checkpoint inhibitor resistance in melanoma with Perturb-Seq.}{Dec 2018}{}{Annual Broad Institute Retreat; Boston, Massachusetts}{\empty}\detaileditem{Single-cell RNA-Seq of melanoma ecosystems reveals sources of T cell exclusion linked to immunotherapy clinical outcomes.}{Jul 2018}{}{Annual Broad Institute-Israel Science Foundation Symposium; Cambridge, Massachusetts}{\empty}\detaileditem{The Center for Cancer Precision Medicine enables exploration of immunotherapy resistance in melanoma at the single-cell level.}{Jun 2018}{}{Annual Dana-Farber / Harvard Cancer Center Genetics Retreat; Boston, Massachusetts}{\empty}\detaileditem{In vitro modeling and analysis of chromosome 8p arm-level deletion using CRISPR-Cas9.}{May 2016}{}{Trinity College Annual Spring Research Symposium; Hartford, Connecticut}{\empty}\detaileditem{Review of integrase-mediated site-specific recombination in mycobacteriophage species.}{May 2013}{}{Trinity College Annual Spring Research Symposium; Hartford, Connecticut}{\empty}}

# Service   

\detailedsection{\detaileditem{Patient Ambassador}{2018}{Boston, Massachusetts}{Dana-Farber Cancer Institute}{\item{Escorted patients to appointments across the Longwood Medical Area}}}

# Skills

\detailedsection{\detaileditem{R (advanced), Bash, Matlab, Python}{}{Programming}{}{\empty}\detaileditem{tissue dissociation, cell line culture, flow cytometry}{}{Cellular biology}{}{\empty}\detaileditem{plasmid cloning, CRISPR gene editing, RNA-seq, ATAC-seq}{}{Molecular biology}{}{\empty}}
